IMDC (HENG)Risk Stratification for Metastatic RCC
Prognostic Tier
Scoring Definition
- Favorable: 0 risk factors.
- Intermediate: 1-2 risk factors.
- Poor: 3-6 risk factors.
Guidelines & Evidence
Verified
Last Review: 2026
Last Comprehensive Review: 2026
Clinical Context
We think this might be relevant to the clinical guidance for IMDC (Heng) Criteria for Metastatic RCC.
Clinical Context
We think this might be relevant to the clinical guidance for IMDC (Heng) Criteria for Metastatic RCC.
Clinical Context
We think this might be relevant to the clinical guidance for IMDC (Heng) Criteria for Metastatic RCC.
IMDC (HENG)Risk Stratification for Metastatic RCC
Scoring Definition
Treatment Impact
Clinical Strategy
Favorable risk group. First-line therapy often includes TKI monotherapy (e.g., Sunitinib, Pazopanib) or TKI/IO combinations.
Verified
Last Review: 2026
Last Comprehensive Review: 2026
